ROS and radiotherapy: more we care
Oncotarget
.
2017 May 30;8(22):35482-35483.
doi: 10.18632/oncotarget.16613.
Author
Pierre Sonveaux
1
Affiliation
1
Pole of Pharmacology, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium.
PMID:
28415657
PMCID:
PMC5482588
DOI:
10.18632/oncotarget.16613
No abstract available
Keywords:
auranofin; radiotherapy; reactive oxygen species; thioredoxin; tumor metabolism.
Publication types
News